Lobbying client · LD-2 disclosures
Milanapharm
Alabama
30 filings from 1 registrant · 2019–2026 · latest filed Jul 20, 2026
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
13 filings
Budget/Appropriations
BUD
2 filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
- H.R. 2740 116th CongressLabor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 20205 filingsthrough 2020
- H.R. 2968 116th CongressMaking appropriations for the Department of Defense for the fiscal year ending September 30, 2020, and for other purposes.5 filingsthrough 2020
- S. 2474
Who did the lobbying
Every lobbyist named on this client's filings.
- Zachary Williams Forbes-Tate14 filingsthrough 2022
- Wesley Ryan Welch Forbes-TateCovered position: Legislative Director, Senator Richard Shelby Legislative Assistant, Senator Richard Shelby Legislative Correspondent, Senator Richard Shelby14 filingsthrough 2022
- EDWARD C. RENO iii Forbes-Tate14 filingsthrough 2022
- Derrick M White Forbes-TateCovered position: Deputy Communications Director, Senator Orrin Hatch10 filingsthrough 2021
2 of 4 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
The 20 most recent of 30 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: milanapharm.